Supplementary Figure from Accounting for &lt;i&gt;EGFR&lt;/i&gt; Mutations in Epidemiologic Analyses of Non–Small Cell Lung Cancers: Examples Based on the International Lung Cancer Consortium Data

Sabine Schmid; Mei Jiang; M. Catherine Brown; Aline Fusco Fares; Miguel García-Pardo; Joelle Soriano; Mei Dong; Sera Thomas; Takashi Kohno; Letícia Ferro Leal; Nancy Diao; Juntao Xie; Zhichao Wang; Давид Заридзе; Ivana Holcátová; Jolanta Lissowska; Beata Świątkowska; Dana Mateș; Milan Savić; Angela S. Wenzlaff; Curtis C. Harris; Neil E. Caporaso; Hongxia Ma; Guillermo Fernández‐Tardón; Matt J. Barnett; Gary Goodman; Michael Davies; Mónica Pérez‐Ríos; Fiona Taylor; Eric J. Duell; Ben Schoettker; Hermann Brenner; Angeline S. Andrew; Angela Cox; Alberto Ruano‐Raviña; John K. Field; Loı̈c Le Marchand; Ying Wang; Chu Chen; Adonina Tardón; Sanjay Shete; Matthew B. Schabath; Hongbing Shen; Maria Teresa Landi; Bríd M. Ryan; Ann G. Schwartz; Lihong Qi; Lori C. Sakoda; Paul Brennan; Ping Yang; Jie Zhang; David C. Christiani; Rui Manuel Reis; Kouya Shiraishi; Rayjean J. Hung; Wei Xu; Geoffrey Liu

doi:10.1158/1055-9965.30722123

Article2025

Data from Accounting for EGFR Mutations in Epidemiologic Analyses of Non–Small Cell Lung Cancers: Examples Based on the International Lung Cancer Consortium Data

Sabine Schmid, Mei Jiang, M. Catherine Brown, Aline Fusco Fares, Miguel García-Pardo, Joelle Soriano, Mei Dong, Sera Thomas, Takashi Kohno, Letícia Ferro Leal, Nancy Diao, Juntao Xie, Zhichao Wang, David Zaridze, Ivana Holcátová, Jolanta Lissowska, Beata Świątkowska, Dana Mateș, Milan Savić, Angela S. Wenzlaff, Curtis C. Harris, Neil E. Caporaso, Hongxia Ma, Guillermo Fernández‐Tardón, Matt J. Barnett, Gary Goodman, Michael Davies, Mónica Pérez‐Ríos, Fiona Taylor, Eric J. Duell, Ben Schoettker, Hermann Brenner, Angeline S. Andrew, Angela Cox, Alberto Ruano‐Raviña, John K. Field, Loı̈c Le Marchand, Ying Wang, Chu Chen, Adonina Tardón, Sanjay Shete, Matthew B. Schabath, Hongbing Shen, Maria Teresa Landi, Bríd M. Ryan, Ann G. Schwartz, Lihong Qi, Lori C. Sakoda, Paul Brennan, Ping Yang, Jie Zhang, David C. Christiani, Rui Manuel Reis, Kouya Shiraishi, Rayjean J. Hung, Wei Xu, Geoffrey Liu

Preprint2023

Data from Pan-Cancer Efficacy of Vemurafenib in BRAFV600-Mutant Non-Melanoma Cancers

Vivek Subbiah, Igor Puzanov, Jean Yves Blay, Ian Chau, A. Craig Lockhart, Noopur Raje, Juergen Wolf, José Baselga, Funda Meric‐Bernstam, Jason Roszik, Eli L. Diamond, Gregory J. Riely, Eric J. Sherman, Todd Riehl, Bethany Pitcher, David M. Hyman

Preprint2023

Data from Pan-Cancer Efficacy of Vemurafenib in BRAFV600-Mutant Non-Melanoma Cancers

Vivek Subbiah, Igor Puzanov, Jean Yves Blay, Ian Chau, A. Craig Lockhart, Noopur Raje, Juergen Wolf, José Baselga, Funda Meric‐Bernstam, Jason Roszik, Eli L. Diamond, Gregory J. Riely, Eric J. Sherman, Todd Riehl, Bethany Pitcher, David M. Hyman

Preprint2023

Data from A Novel Epidermal Growth Factor Receptor Inhibitor Promotes Apoptosis in Non–Small Cell Lung Cancer Cells Resistant to Erlotinib

Thibault De La Motte Rouge, Lorenzo Galluzzi, Ken A. Olaussen, Yaël Zermati, Ezgi Tasdemir, Thomas Robert, Hugues Ripoche, Vladimir Lazar, Philippe Dessen, Francis Harper, Gérard Pierron, Guillaume Pinna, Natália M. Araujo, Annick Harel-Belan, Jean‐Pierre Armand, Tai W. Wong, Jean Charles Soria, Guido Guido Kroemer

Preprint2023

Data from A Novel Epidermal Growth Factor Receptor Inhibitor Promotes Apoptosis in Non–Small Cell Lung Cancer Cells Resistant to Erlotinib

Thibault De La Motte Rouge, Lorenzo Galluzzi, Ken A. Olaussen, Yaël Zermati, Ezgi Tasdemir, Thomas Robert, Hugues Ripoche, Vladimir Lazar, Philippe Dessen, Francis Harper, Gérard Pierron, Guillaume Pinna, Natália M. Araujo, Annick Harel-Belan, Jean‐Pierre Armand, Tai W. Wong, Jean Charles Soria, Guido Guido Kroemer

Supplementary Figure from Accounting for <i>EGFR</i> Mutations in Epidemiologic Analyses of Non–Small Cell Lung Cancers: Examples Based on the International Lung Cancer Consortium Data

Abstract

Discussion(0)

Related publications

Data from Accounting for <i>EGFR</i> Mutations in Epidemiologic Analyses of Non–Small Cell Lung Cancers: Examples Based on the International Lung Cancer Consortium Data

Data from Pan-Cancer Efficacy of Vemurafenib in <i>BRAF</i><sup>V600</sup>-Mutant Non-Melanoma Cancers

Data from Pan-Cancer Efficacy of Vemurafenib in <i>BRAF</i><sup>V600</sup>-Mutant Non-Melanoma Cancers

Data from A Novel Epidermal Growth Factor Receptor Inhibitor Promotes Apoptosis in Non–Small Cell Lung Cancer Cells Resistant to Erlotinib

Data from A Novel Epidermal Growth Factor Receptor Inhibitor Promotes Apoptosis in Non–Small Cell Lung Cancer Cells Resistant to Erlotinib

Supplementary Figure from Accounting for &lt;i&gt;EGFR&lt;/i&gt; Mutations in Epidemiologic Analyses of Non–Small Cell Lung Cancers: Examples Based on the International Lung Cancer Consortium Data

Abstract

Discussion(0)

Related publications

Data from Accounting for &lt;i&gt;EGFR&lt;/i&gt; Mutations in Epidemiologic Analyses of Non–Small Cell Lung Cancers: Examples Based on the International Lung Cancer Consortium Data

Data from Pan-Cancer Efficacy of Vemurafenib in &lt;i&gt;BRAF&lt;/i&gt;&lt;sup&gt;V600&lt;/sup&gt;-Mutant Non-Melanoma Cancers

Data from Pan-Cancer Efficacy of Vemurafenib in &lt;i&gt;BRAF&lt;/i&gt;&lt;sup&gt;V600&lt;/sup&gt;-Mutant Non-Melanoma Cancers

Data from A Novel Epidermal Growth Factor Receptor Inhibitor Promotes Apoptosis in Non–Small Cell Lung Cancer Cells Resistant to Erlotinib

Data from A Novel Epidermal Growth Factor Receptor Inhibitor Promotes Apoptosis in Non–Small Cell Lung Cancer Cells Resistant to Erlotinib

Supplementary Figure from Accounting for <i>EGFR</i> Mutations in Epidemiologic Analyses of Non–Small Cell Lung Cancers: Examples Based on the International Lung Cancer Consortium Data

Data from Accounting for <i>EGFR</i> Mutations in Epidemiologic Analyses of Non–Small Cell Lung Cancers: Examples Based on the International Lung Cancer Consortium Data

Data from Pan-Cancer Efficacy of Vemurafenib in <i>BRAF</i><sup>V600</sup>-Mutant Non-Melanoma Cancers

Data from Pan-Cancer Efficacy of Vemurafenib in <i>BRAF</i><sup>V600</sup>-Mutant Non-Melanoma Cancers